LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION

Size: px
Start display at page:

Download "LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION"

Transcription

1 LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION Murray Grossman University of Pennsylvania Support from NIH (AG17586, AG15116, NS44266, NS35867, AG32953, AG38490), IARPA, ALS Association, and the Wyncote Foundation Consultant for TauRx and Forum Pharmaceuticals No conflict of interest to declare

2 LANGUAGE IN FRONTOTEMPORAL DEGENERATION Language is a uniquely human process Single words are used to construct sentences Sentences are used in conversations Inexpensive screening device with potentially high sensitivity and specificity for FTD spectrum pathology Disease-modifying treatment trials

3 LANGUAGE IN FRONTOTEMPORAL DEGENERATION Plan of talk Disorders of language in aphasic and non-non-aphasic variants of FTD Semantic variant PPA Non-fluent/agrammatic PPA Behavioral variant FTD Impairments in FTD selectively compromise each level of language Markers for specific FTD pathology

4 FRONTOTEMPORAL DEGENERATION Two major phenotypes Primary progressive aphasia Semantic variant PPA (Semantic dementia) Nonfluent/agrammatic PPA (Progressive non-fluent aphasia) Behavioral variant frontotemporal degeneration SD PNFA bvftd

5 SEMANTIC VARIANT PPA Lexical semantic and object knowledge is compromised in

6 VISUAL FEATURE KNOWLEDGE IN SEMANTIC VARIANT PPA Degraded object concepts in svppa Difficulty with naming and comprehension Less impaired abstract concepts % rect Degraded visual features of objects Disease in visual association cortex co r HAND G LOVE SHOE z-score Two-alternative forced-choice ABSTRACT CONCRETE CONTROL svppa Bonner et al, 2009

7 NUMBER CONCEPTS IN svppa Despite profound word comprehension and object knowledge deficits, svppa patients are rapid and accurate at performing written number calculations

8 MUSIC IN svppa Weinstein et al, 2011 Preserved music knowledge in svppa

9 PATHOLOGY IN SEMANTIC VARIANT PPA Autopsy shows anterior temporal atrophy Neuronal dropout in superficial layers TDP-43 neuronal inclusions Found in about 85% of cases

10 SPECTRUM OF CLINICAL DISEASE IN TDP-43 PATHOLOGY TDP-43 pathology in both FTLD and ALS ALS ALS FTLD FTLD FTLD-ALS link confirmed by TARDBP mutation and C9orf72 expansion

11 McCluskey et al, 2014 SPECTRUM OF CLINICAL DISEASE IN TDP-43 PATHOLOGY ALS-classic Pyramidal/neuromuscular disease ALS is a multi-system disorder 10% with ALS-FTD 34% with ALS-MCI 15% with ALS-Plus ALS with cerebellar, extrapyramidal, oculomotor, 40 or autonomic features Significantly poorer prognosis, 20 marker for inherited disease 0 months survival ALS-classic ALS-Plus

12 SEMANTIC VARIANT PPA Semantic variant PPA Degraded representations of single word and object concepts Preserved number and music concepts Related to anterior and ventral temporal disease Clinical marker for TDP-43 pathology Pathology shared with ALS

13 NON-FLUENT/AGRAMMATIC PPA Speech fluency and grammatical comprehension are impaired in progressive

14 NON-FLUENT/AGRAMMATIC PPA Significantly slowed speech Significant grammatical deficit - Expression deficit Significantly simplified grammar in utterances - Comprehension deficit Significantly impaired grammatical comprehension Impaired oral and written langu 100 ect r 90 cor 80 % 70 frontal and superior temporal atrophy Gunawardena Dual white et al, 2010 matter routes % complex structures nap PA nappa svppa bvftd Control words/minute # age Ash et al, 2010 control Grossman et al, cleft 2014 center Grammatical deficit related to left inferior * * * Charles et al, 2014 svppa

15 NON-FLUENT/AGRAMMATIC PPA nappa deficit is selective nappa are good at naming and complex figure construction z-score Boston Naming Rey Figure Copy nappa svppa bvftd CBD Libon et al, 2010

16 NON-FLUENT/AGRAMMATIC PPA Gross pathology in non-fluent/agrammatic PPA

17 NON-FLUENT/AGRAMMATIC PPA Pick bodies balloon cells Courtesy John Q. Trojanowski MD, PhD Microscopic pathology in non-fluent/agrammatic PPA H & E preparation Tau-immunoreactive histopathology Misfolded tau due to hyperphosphorylation Disturbs microtubule structure Tau found in about 75% of cases

18 SPECTRUM OF CLINICAL DISEASE IN TAU PATHOLOGY Ta u pathology in both nappa and PSP/ FTLD% PSP/CBD%

19 SPECTRUM OF CLINICAL DISEASE IN TAU PATHOLOGY Anatomic distribution of tau pathology in PSP and CBD PSP CBD Irwin et al, 2012

20 NON-FLUENT/AGRAMMATIC PPA Non-fluent/agrammatic PPA Specific pattern of impaired language due to limited grammatical processing Associated with left inferior frontal disease Similar pathology in akinetic-rigid disorders such as CBD and PSP Clinical screen for tau pathology

21 BEHAVIORAL VARIANT FRONTOTEMPORAL DEGENERATION Poor self-regulation, impulsive, disinhibited Rigid, obsessive, rituals Apathetic Lack of insight Poor empathy

22 BEHAVIORAL VARIANT FRONTOTEMPORAL DEGENERATION Frontal and anterior temporal gray matter Extensive white matter disease

23 BEHAVIORAL VARIANT FRONTOTEMPORAL DEGENERATION Impaired social judgment in bvftd b vftd impaired Correlation with comp of social judgments cartoon prediction flexibility ToM 2nd order onents empathy Eslinger et al, 2007

24 SEMISTRUCTURED SPEECH SAMPLE Wordless picture story, 30 events, 7 episodes Single word expression Sentence expression Narrative organization

25 BEHAVIORAL VARIANT FRONTOTEMPORAL DEGENERATION Accurate description of content of children s wordless p icture story Poor organization of % global connectedness narrative No sense of the p oint of the story bvftd nappa svppa c ontrol Impaired global connectedness Impaired local connectedness Impaired theme maintenance Ash et al, 2006 Reduced connectedness related to prefrontal atrophy

26 BEHAVIORAL VARIANT FRONTOTEMPORAL DEGENERATION Atrophy in behavioral variant frontotemporal degeneration 50% TDP-43 pathology, 50% tau pathology

27 DIAGNOSIS IN FRONTOTEMPORAL DEGENERATION Multimodal strategy for diagnosis CLINICAL MRI MOLECULAR GENETIC CSF

28 FAMILIAL FRONTOTEMPORAL DEGENERATION FTLD autosomal dominant inheritance in 25.1% Mutation identified in 20.1% of patients Chromosome 17 MAPT Chromosome 17 GRN Chromosome 9 C9orf72 Chromosome 9 VCP Chromosome 3 CHMP2B Chromosome 1 TARDBP Specific pathology associated with each mutation

29 IMAGING BIOMARKERS FOR YOUNG ONSET FTD Eigenanatomy imaging distinguishes FTLD-tau from FTLD-TDP with known pathology tau TDP WM myelin WM inclusions GM neuronal dropout GM inclusions McMillan et al, 2013

30 BIOFLUID BIOMARKERS FOR FTLD CSF phosphorylated tau abnormal in tauopathy Elevated CSF ptau:ttau in tauopathy Lower ptau:ttau in TDP-43 proteinopathy Related to motor and PFC in ALS Grossman et al, 2014 Related to midbrain in PSP

31 McMillan et al, 2014 MOLECULAR BIOMARKERS IN HUMAN TAUOPATHY Myelin oligodendrocyte basic protein Stabilizes myelin rs (MOBP) is associated with reduced white matter fractional anisotropy in midbrain and superior longitudinal fasciculus Locus of white matter pathology in progressive pathology

32 MOLECULAR BIOMARKERS IN HUMAN TAUOPATHY Minor T allele at rs of MOBP associated with reduced survival in clinical FTD and known tauopathy clinical FTD known tau pathology Irwin et al, 2014 Validated by imaging-guided biopsy of SLF showing diseased myelin in risk allele carriers (right) Minor T allele at rs of MOBP associated with reduced FA in white matter of superior longitudinal fasciculus and brain stem

33 LANGUAGE IN FRONTOTEMPORAL DEGENERATION Language is a complex process that can serve as a sensitive and inexpensive screen for FTD Single words and object knowledge compromised in semantic variant PPA Marker of TDP-43 pathology Grammatical expression and comprehension impaired in non-fluent/ agrammatic PPA Marker of tau pathology Narrative conversation difficulty in

34

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer MRC Clinician Scientist Honorary Consultant Neurologist Dementia Research Centre, UCL Institute of Neurology

More information

! slow, progressive, permanent loss of neurologic function.

! slow, progressive, permanent loss of neurologic function. UBC ! slow, progressive, permanent loss of neurologic function.! cause unknown.! sporadic, familial or inherited.! degeneration of specific brain region! clinical syndrome.! pathology: abnormal accumulation

More information

FTD basics! Etienne de Villers-Sidani, MD!

FTD basics! Etienne de Villers-Sidani, MD! FTD basics! Etienne de Villers-Sidani, MD! Frontotemporal lobar degeneration (FTLD) comprises 3 clinical syndromes! Frontotemporal dementia (behavioral variant FTD)! Semantic dementia (temporal variant

More information

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Dementia Update Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Nothing to disclose Dementia Progressive deterioration in mental function

More information

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia Bradley F. Boeve, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Alzheimer s Disease

More information

Form D1: Clinician Diagnosis

Form D1: Clinician Diagnosis Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.

More information

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS Norman L. Foster, M.D. Director, Center for Alzheimer s Care, Imaging and Research Chief, Division of Cognitive Neurology, Department of Neurology

More information

Biomarkers: Translating Research into Clinical Practice

Biomarkers: Translating Research into Clinical Practice Biomarkers: Translating Research into Clinical Practice AFTD Education Conference San Diego, April 2015 Nadine Tatton, PhD Scientific Director, AFTD HelpLine 866-5507-7222 u info@theaftd.org u www.theaftd.org

More information

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit Objectives RAIN Difficult Diagnosis 2014: A 75 year old woman with falls Alexandra Nelson MD, PhD UCSF Memory and Aging Center/Gladstone Institute of Neurological Disease Recognize important clinical features

More information

I do not have any disclosures

I do not have any disclosures Alzheimer s Disease: Update on Research, Treatment & Care Clinicopathological Classifications of FTD and Related Disorders Keith A. Josephs, MST, MD, MS Associate Professor & Consultant of Neurology Mayo

More information

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney. I.1 I.2 II.1 II.2 II.3 II.4 II.5 II.6 III.1 III.2 III.3 III.4 III.5 III.6 III.7 III.8 III.9 III.10 III.11 III.12 IV.1 IV.2 IV.3 IV.4 IV.5 Frontotemporal Dementia: Towards better diagnosis Frontotemporal

More information

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009 Sandra Weintraub, Ph.D. Clinical Core Director, Cognitive Neurology and Alzheimer s Disease Center Northwestern University Feinberg School of Medicine Chicago, Illinois Dementia: a condition caused by

More information

Clinical Genetics & Dementia

Clinical Genetics & Dementia Clinical Genetics & Dementia Dr Nayana Lahiri Consultant in Clinical Genetics & Honorary Senior Lecturer Nayana.lahiri@nhs.net Aims of the Session To appreciate the potential utility of family history

More information

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion Alzheimer s and Dementia Research: An Advanced Discussion Brad Boeve, MD Department of Neurology Mayo Clinic Alzheimer s and Dementia Research: An Advanced Discussion Theoretical Constructs in Aging/Dementia

More information

Sandra Weintraub, PhD Clinical Core Leader and Professor

Sandra Weintraub, PhD Clinical Core Leader and Professor Sandra Weintraub, PhD Clinical Core Leader and Professor Northwestern Cognitive Neurology and Alzheimer s Disease Center (CNADC) Chicago, Illinois www.brain.northwestern.edu Why is it so difficult to diagnose

More information

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD OBJECTIVES Terminology/Dementia Basics Most Common Types Defining features Neuro-anatomical/pathological underpinnings Neuro-cognitive

More information

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce ALESSANDRO MARTORANA UOC NEUROLOGIA-CENTRO ALZHEIMER POLICLINICO TOR VERGATA-UNIVERSITÀ DI ROMA TOR VERGATA

More information

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California The National Cell Repository for Alzheimer s Disease (NCRAD) is a data and specimen collection source for families with Alzheimer disease (AD) or serious memory loss. Families having two or more living

More information

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal

More information

Phenotypic Variability in ALS

Phenotypic Variability in ALS Phenotypic Variability in ALS Michael A. Elliott, MD, FAAN Medical Director, ALS Clinic Swedish Neuroscience Institute 1 Outline ALS Background Description Typical Presentation Clinical Phenotype Motor

More information

Frontotemporal dementia:

Frontotemporal dementia: Frontotemporal dementia: Where we ve been What s on the horizon Howard Rosen, M.D. UCSF Department of Neurology Memory and Aging Center www.memory.ucsf.edu None Disclosures Overview FTD, What is it? Origins

More information

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1 Frontotemporal Degeneration and Primary Progressive Aphasia Caregiver and Professional Education Conference Diana R. Kerwin, MD Assistant Professor of Medicine-Geriatrics Cognitive Neurology and Alzheimer

More information

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration Annual Scientific Meeting Canadian Geriatric Society Philippe Desmarais,

More information

Aging often includes changes to vision, hearing, taste, smell, skin, hair, weight & changes to Brain:

Aging often includes changes to vision, hearing, taste, smell, skin, hair, weight & changes to Brain: Aging & Cognition Ladan Ghazi Saidi, Ph.D., Assistant Professor, Department of Communication Disorders, COE, University of Nebraska at Kearney 2018 Nebraska Speech-Language-Hearing Association Fall Convention

More information

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Dementia Update October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Outline New concepts in Alzheimer disease Biomarkers and in vivo diagnosis Future trends

More information

The genetics and neuropathology of frontotemporal lobar degeneration

The genetics and neuropathology of frontotemporal lobar degeneration Acta Neuropathol (2012) 124:353 372 DOI 10.1007/s00401-012-1029-x REVIEW The genetics and neuropathology of frontotemporal lobar degeneration Anne Sieben Tim Van Langenhove Sebastiaan Engelborghs Jean-Jacques

More information

Biomarkers to Identify the Pathological Basis for Frontotemporal Lobar Degeneration

Biomarkers to Identify the Pathological Basis for Frontotemporal Lobar Degeneration J Mol Neurosci (2011) 45:366 371 DOI 10.1007/s12031-011-9597-0 Biomarkers to Identify the Pathological Basis for Frontotemporal Lobar Degeneration Murray Grossman Received: 6 June 2011 /Accepted: 11 July

More information

Presenter Disclosure Information. I have no financial relationships to disclose:

Presenter Disclosure Information. I have no financial relationships to disclose: Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois http://www.brain.northwestern.edu/dementia/ppa/index.html

More information

Brain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1

Brain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1 Brain Advance Access published February 25, 2014 doi:10.1093/brain/awu024 Brain 2014: Page 1 of 17 1 BRAIN A JOURNAL OF NEUROLOGY Asymmetry and heterogeneity of Alzheimer s and frontotemporal pathology

More information

Prof Tim Anderson. Neurologist University of Otago Christchurch

Prof Tim Anderson. Neurologist University of Otago Christchurch Prof Tim Anderson Neurologist University of Otago Christchurch Tim Anderson Christchurch Insidious cognitive loss From subjective memory complaints (SMC) to dementia Case 1. AR. 64 yrs Male GP referral

More information

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease

More information

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer

More information

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia Dementia: broad term for any acquired brain condition impairing mental function such that ADLs are impaired. Includes:

More information

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril Neurodegenerative disorders to be discussed Alzheimer s disease Lewy body diseases Frontotemporal dementia and other tauopathies Huntington s disease Motor Neuron Disease 2 Neuropathology of neurodegeneration

More information

What is. frontotemporal. address? dementia?

What is. frontotemporal. address? dementia? What is frontotemporal address? dementia? Contents 03 What is frontotemporal dementia? 04 Symptoms 05 Diagnosis 06 Treatments Information in this booklet is for anyone who wants to know more about frontotemporal

More information

Form A3: Subject Family History

Form A3: Subject Family History Initial Visit Packet NACC Uniform Data Set (UDS) Form A: Subject Family History ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by a clinician

More information

Paper Title Theme Presentation Type Poster Presentatio n Day

Paper Title Theme Presentation Type Poster Presentatio n Day A NOVEL PROBE OF FUNCTIONAL NETWORK ARCHITECTURE IN PROTEINOPATHIES: SPECTRAL DCM IN SEMANTIC DEMENTIA Blood and imaging biomarkers Poster and Data Blitz Monday 1 M1 PATHWAYS PREDICTION & RISK-GENE PRIORITIZATION

More information

Diffusion Tensor Imaging in Dementia. Howard Rosen UCSF Department of Neurology Memory and Aging Center

Diffusion Tensor Imaging in Dementia. Howard Rosen UCSF Department of Neurology Memory and Aging Center Diffusion Tensor Imaging in Dementia Howard Rosen UCSF Department of Neurology Memory and Aging Center www.memory.ucsf.edu Overview Examples of DTI findings in Alzheimer s disease And other dementias Explore

More information

2016 Programs & Information

2016 Programs & Information Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia

More information

Frontotemporal Degeneration

Frontotemporal Degeneration #96100 Frontotemporal Degeneration COURSE #96100 2 CONTACT/CLOCK HOURS Release Date: 11/01/15 Expiration Date: 10/31/18 Frontotemporal Degeneration HOW TO RECEIVE CREDIT Read the enclosed course. Complete

More information

ALS, Cognitive Impairment (CI) and Frontotemporal Lobar Dementia (FTLD): A Professional s Guide

ALS, Cognitive Impairment (CI) and Frontotemporal Lobar Dementia (FTLD): A Professional s Guide ALS, Cognitive Impairment (CI) and Frontotemporal Lobar Dementia (FTLD): A Professional s Guide Overview A link between ALS and cognitive dysfunction was first noted in the late 1800 s, but only in the

More information

FRONTO TEMPORAL DEMENTIA

FRONTO TEMPORAL DEMENTIA FRONTO TEMPORAL DEMENTIA Dr. Diana Paleacu Kertesz Neurology Service and Memory Clinic Abarbanel Mental Health Center Department of Neurology, Tel Aviv University DAT: 55-60% VD: 15-20% DLBD: 15-20% FTD:

More information

FRONTO TEMPORAL DEMENTIA

FRONTO TEMPORAL DEMENTIA FRONTO TEMPORAL DEMENTIA Dr. Diana Paleacu Kertesz Neurology Service and Memory Clinic Abarbanel Mental Health Center Department of Neurology, Tel Aviv University Fronto-Temporal Lobe Dementia (FTLD) DAT:

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Devenney E, Bartley L, Hoon C, et al. Progression in behavioral variant frontotemporal dementia: a longitudinal study. JAMA Neurol. Published online October 26, 2015. doi:10.1001/jamaneurol.2015.2061.

More information

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14.

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14. NIH Public Access Author Manuscript Published in final edited form as: Semin Neurol. 2013 September ; 33(4): 386 416. doi:10.1055/s-0033-1359312. Neuroimaging Biomarkers of Neurodegenerative Diseases and

More information

Confronting the Clinical Challenges of Frontotemporal Dementia

Confronting the Clinical Challenges of Frontotemporal Dementia Confronting the Clinical Challenges of Frontotemporal Dementia A look at FTD s symptoms, pathophysiology, subtypes, as well as the latest from imaging studies. By Zac Haughn, Senior Associate Editor Ask

More information

FTD Genetics: for patients and families. Kirk Wilhelmsen, M.D., Ph.D UNC

FTD Genetics: for patients and families. Kirk Wilhelmsen, M.D., Ph.D UNC FTD Genetics: for patients and families Kirk Wilhelmsen, M.D., Ph.D UNC UNC The Human Genome 22 Pairs of Chromosomes 2 Sex Chromosomes 3,300,000,000 basepairs of DN 7-14 picograms of DN per cell ~20,000

More information

What is frontotemporal dementia?

What is frontotemporal dementia? What is frontotemporal dementia? Introduction Information in this introductory booklet is for anyone who wants to know more about frontotemporal dementia (FTD). This includes people living with FTD, their

More information

Dementia Past, Present and Future

Dementia Past, Present and Future Dementia Past, Present and Future Morris Freedman MD, FRCPC Division of Neurology Baycrest and University of Toronto Rotman Research Institute, Baycrest CNSF 2015 Objectives By the end of this presentation,

More information

genetics 101 FTD/PPA Family Caregiver and Professional Education and Support Conference 2012

genetics 101 FTD/PPA Family Caregiver and Professional Education and Support Conference 2012 agenda genetic counseling genetics 101 genetics of FTD and PPA Lisa Kinsley, MS, CGC, genetic counselor HyungSub Shim, MD, neurology fellow, CNADC how does my fit in? what to expect what is a genetic counselor?

More information

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language

More information

DEFINING THE NEUROPSYCHOLOGICAL AND NEUROIMAGING PHENOTYPE OF BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA SUBMITTED TO UNIVERSITY COLLEGE LONDON

DEFINING THE NEUROPSYCHOLOGICAL AND NEUROIMAGING PHENOTYPE OF BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA SUBMITTED TO UNIVERSITY COLLEGE LONDON DEFINING THE NEUROPSYCHOLOGICAL AND NEUROIMAGING PHENOTYPE OF BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA SUBMITTED TO UNIVERSITY COLLEGE LONDON FOR THE DEGREE OF DOCTOR OF PHILOSOPHY LAURA EMILY DOWNEY

More information

Differential Longitudinal Decline on the Mini-Mental State Examination in Frontotemporal Lobar Degeneration and Alzheimer Disease

Differential Longitudinal Decline on the Mini-Mental State Examination in Frontotemporal Lobar Degeneration and Alzheimer Disease ORIGINAL ARTICLE Differential Longitudinal Decline on the Mini-Mental State Examination in Frontotemporal Lobar Degeneration and Alzheimer Disease Kay See Tan, MS,* David J. Libon, PhD,w Katya Rascovsky,

More information

FTD: Improving Outcomes & Outreach

FTD: Improving Outcomes & Outreach 2nd Annual Frontotemporal Degeneration Caregiver Education Conference Raleigh, NC 7.25.12 FTD: Improving Outcomes & Outreach Dan Kaufer, MD Associate Professor, Neurology Director, Memory Disorders Program

More information

ALS and Frontotemporal Dementia. Catherine Lomen-Hoerth, MD, PhD Professor of Neurology University of California, San Francisco

ALS and Frontotemporal Dementia. Catherine Lomen-Hoerth, MD, PhD Professor of Neurology University of California, San Francisco ALS and Frontotemporal Dementia Catherine Lomen-Hoerth, MD, PhD Professor of Neurology University of California, San Francisco Clinical Features Upper motor neuron findings Slow speech Brisk gag and jaw

More information

Dr Fiona Kumfor University of Sydney

Dr Fiona Kumfor University of Sydney Social Cognition in Dementia: Informing Diagnosis, Prognosis and Management Dr Fiona Kumfor University of Sydney CHANGES IN DEMENTIA Memory Social cognition Language ELEMENTS OF SOCIAL COGNITION Face processing

More information

What is frontotemporal dementia (FTD)?

What is frontotemporal dementia (FTD)? What is frontotemporal dementia (FTD)? Factsheet 404LP April 2016 Frontotemporal dementia (FTD) is one of the less common types of dementia. The term covers a wide range of different conditions. It is

More information

FTD Genetics: for patients and families. Kirk Wilhelmsen, M.D., Ph.D UNC

FTD Genetics: for patients and families. Kirk Wilhelmsen, M.D., Ph.D UNC FTD Genetics: for patients and families Kirk Wilhelmsen, M.D., Ph.D UNC UNC The Human Genome 22 Pairs of Chromosomes 2 Sex Chromosomes 3,300,000,000 basepairs of DN 7-14 picograms of DN per cell ~20,000

More information

Selective Vulnerability of von Economo Neurons in Frontotemporal Dementia

Selective Vulnerability of von Economo Neurons in Frontotemporal Dementia Selective Vulnerability of von Economo Neurons in Frontotemporal Dementia William W. Seeley, MD Assistant Professor of Neurology UCSF August 3, 2007 Function Region/Network Neuron Molecule Gene Why study

More information

FTD/PPA Caregiver Education Conference March 11, 2011

FTD/PPA Caregiver Education Conference March 11, 2011 FTD/PPA Caregiver Education Conference March 11, 2011 Question and Answer Session Answered by Joseph Cooper, MD, Darby Morhardt, MSW, LCSW, Mary O Hara, AM, LCSW, Jaimie Robinson, MSW, LCSW, Emily Rogalski,

More information

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort doi:10.1093/brain/awv358 BRAIN 2016: 139; 452 467 452 Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort Sara Van Mossevelde, 1,2,3,4 Julie van

More information

C9orf72 promoter hypermethylation is neuroprotective Neuroimaging and neuropathologic evidence

C9orf72 promoter hypermethylation is neuroprotective Neuroimaging and neuropathologic evidence Published Ahead of Print on March 20, 2015 as 10.1212/WNL.0000000000001495 C9orf72 promoter hypermethylation is neuroprotective Neuroimaging and neuropathologic evidence Corey T. McMillan, PhD Jenny Russ,

More information

AGING, DEMENTIA, COGNITIVE AND BEHAVIOURAL NEUROLOGY

AGING, DEMENTIA, COGNITIVE AND BEHAVIOURAL NEUROLOGY AGING, DEMENTIA, COGNITIVE AND BEHAVIOURAL NEUROLOGY Professor Tim Lynch Dublin Neurological Institute at the Mater Misericordiae University Hospital University College Dublin Dublin, IRELAND This Case-based

More information

Narrative discourse deficits in amyotrophic lateral sclerosis

Narrative discourse deficits in amyotrophic lateral sclerosis Narrative discourse deficits in amyotrophic lateral sclerosis Sharon Ash, PhD Anna Menaged, BA Christopher Olm, BA Corey T. McMillan, PhD Ashley Boller, BA David J. Irwin, MD Leo McCluskey, MD Lauren Elman,

More information

Frontotemporal Dementia

Frontotemporal Dementia Frontotemporal Dementia clinical, genetic, and pathological heterogeneity Harro Seelaar The studies in this thesis were funded by: Stichting Dioraphte Hersenstichting Nederland Prinses Beatrix Fonds Nuts

More information

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup Woollacott et al. Alzheimer's Research & Therapy (2018) 10:79 https://doi.org/10.1186/s13195-018-0405-8 RESEARCH Open Access Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by

More information

Overview of the non-alzheimer Dementias

Overview of the non-alzheimer Dementias Overview of the non-alzheimer Dementias Chiadi U. Onyike, MD, MHS FTD/Young-Onset Dementias Program Johns Hopkins Neuropsychiatry Disclaimer Dr. Onyike is a principal investigator for the Baltimore site

More information

doi: /brain/awr198 Brain 2011: 134;

doi: /brain/awr198 Brain 2011: 134; doi:10.1093/brain/awr198 Brain 2011: 134; 2565 2581 2565 BRAIN A JOURNAL OF NEUROLOGY Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration Jonathan D. Rohrer,

More information

Clinical phenotypes in autopsy-confirmed Pick disease

Clinical phenotypes in autopsy-confirmed Pick disease Clinical phenotypes in autopsy-confirmed Pick disease O. Piguet, PhD G.M. Halliday, PhD W.G.J. Reid, PhD B. Casey, PhD R. Carman, MPhil Y. Huang, PhD J.H. Xuereb, MD J.R. Hodges, FRCP J.J. Kril, PhD Address

More information

Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis

Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis RESEARCH PAPER Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis David J Irwin, 1 3 Corey T McMillan, 2,3 Johannes Brettschneider,

More information

Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois

Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois Presenter Disclosure Information Employee of: Author of:

More information

02/04/2015. The structure of the talk. Dementia as a motor disorder. Movement, cognition & behaviour. Example 1. Example 2

02/04/2015. The structure of the talk. Dementia as a motor disorder. Movement, cognition & behaviour. Example 1. Example 2 The th Annual Memory Clinic Conference Dublin, Trinity College, 27 March 1 The structure of the talk Dementia as a motor disorder Thomas H. Bak Human Cognitive Neuroscience & Centre for Clinical Brain

More information

The ABCs of Dementia Diagnosis

The ABCs of Dementia Diagnosis The ABCs of Dementia Diagnosis Dr. Robin Heinrichs, Ph.D., ABPP Board Certified Clinical Neuropsychologist Associate Professor, Psychiatry & Behavioral Sciences Director of Neuropsychology Training What

More information

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review 1 Department of Neurology, Erasmus MCdUniversity Medical Centre Rotterdam, Rotterdam, The Netherlands 2 Dementia Research Centre, UCL Institute of Neurology, London, UK 3 Department of Neurology, VU University

More information

Dementia and Aphasia-AD, FTD & aphasia

Dementia and Aphasia-AD, FTD & aphasia 特別講演 Dementia and Aphasia-AD, FTD & aphasia Shunichiro Shinagawa, Bruce L. Miller Key words : Alzheimer s disease, frontotemporal dementia, primary progressive aphasia Alzheimer s disease(ad)and frontotemporal

More information

Frontotemporal Degeneration

Frontotemporal Degeneration #66100 Frontotemporal Degeneration COURSE #66100 2 CE CREDITS Release Date: 11/01/15 Expiration Date: 10/31/18 Frontotemporal Degeneration Faculty Ellen Steinbart, RN, MA, received a Bachelor of Arts from

More information

Non Alzheimer Dementias

Non Alzheimer Dementias Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,

More information

Define functional MRI. Briefly describe fmri image acquisition. Discuss relative functional neuroanatomy. Review clinical applications.

Define functional MRI. Briefly describe fmri image acquisition. Discuss relative functional neuroanatomy. Review clinical applications. Dr. Peter J. Fiester November 14, 2012 Define functional MRI. Briefly describe fmri image acquisition. Discuss relative functional neuroanatomy. Review clinical applications. Briefly discuss a few examples

More information

Outline. Clinicopathologic Conference RAIN Case Presentation. Case Presentation. Pathology Presentation. Closing Remarks

Outline. Clinicopathologic Conference RAIN Case Presentation. Case Presentation. Pathology Presentation. Closing Remarks Outline Clinicopathologic Conference RAIN 2017 Case Presenter: Scott Caganap, MD Clinical Discussant: Gil Rabinovici, MD Pathology Discussant: Lea Grinberg, MD, PhD Case Presentation 1. History and Exam

More information

Impaired action knowledge in amyotrophic lateral sclerosis

Impaired action knowledge in amyotrophic lateral sclerosis Impaired action knowledge in amyotrophic lateral sclerosis M. Grossman, MD C. Anderson, BA A. Khan, BA B. Avants, PhD L. Elman, MD L. McCluskey, MD Address correspondence and reprint requests to Dr. Murray

More information

Early Onset Dementia From the background to the foreground

Early Onset Dementia From the background to the foreground Early Onset Dementia From the background to the foreground Dr Jeremy Isaacs Consultant Neurologist St George s Hospital Excellence in specialist and community healthcare Themes of my talk The early onset

More information

Frontal Behavioural Inventory (FBI)

Frontal Behavioural Inventory (FBI) This is a Sample version of the Frontal Behavioural Inventory (FBI) The full version of the Frontal Behavioural Inventory (FBI) comes without sample watermark. The full complete version includes Complete

More information

Epidemiology of dementia. TA Treves, MD

Epidemiology of dementia. TA Treves, MD Epidemiology of dementia TA Treves, MD Dementia Definition Multiple Cognitive Deficits: Memory dysfunction especially new learning, a prominent early symptom At least one additional cognitive deficit aphasia,

More information

Moving Targets: An Update on Diagnosing Dementia in the Clinic

Moving Targets: An Update on Diagnosing Dementia in the Clinic Moving Targets: An Update on Diagnosing Dementia in the Clinic Eric McDade DO Department of Neurology School of Medicine Alzheimer Disease Research Center Disclosures No relevant financial disclosures

More information

What is primary progressive aphasia?

What is primary progressive aphasia? What is primary progressive aphasia? Introduction This leaflet is about primary progressive aphasia (PPA), a rare form of dementia. It s for anyone who may be worried about themselves or somebody else.

More information

Dementia. Amber Eker, MD. Assistant Professor Near East University Department of Neurology

Dementia. Amber Eker, MD. Assistant Professor Near East University Department of Neurology Dementia Amber Eker, MD Assistant Professor Near East University Department of Neurology Dementia An acquired syndrome consisting of a decline in memory and other cognitive functions Impairment in social

More information

Lecture 42: Final Review. Martin Wessendorf, Ph.D.

Lecture 42: Final Review. Martin Wessendorf, Ph.D. Lecture 42: Final Review Martin Wessendorf, Ph.D. Lecture 33 cortex Heilbronner 5 lobes of the cortex Lateral view (left side) Mid-saggital view (right side) Cellular organization of cortex White matter

More information

Psy /16 Human Communication. By Joseline

Psy /16 Human Communication. By Joseline Psy-302 11/16 Human Communication By Joseline Lateralization Left Hemisphere dominance in speech production in 95% of right handed and 70% of left handed people Left -> Timing, Sequence of events Right

More information

European Prevention of Alzheimer s Dementia (EPAD)

European Prevention of Alzheimer s Dementia (EPAD) European Prevention of Alzheimer s Dementia (EPAD) Ron Marcus, MD ISCTM Adaptive Design Workshop February 20, 2018 1 EPAD Goal The European Prevention of Alzheimer's Dementia (EPAD) project aims to develop

More information

What s New in Dementia?

What s New in Dementia? What s New in Dementia? Howard Rosen Professor, Department of Neurology UCSF and Aging Center Disclosure Biogen pharmaceuticals Small grant for clinical trials planning Dementia is a growing source of

More information

doi: /brain/awt165 Brain 2013: 136; Comparative semantic profiles in semantic dementia and Alzheimer s disease

doi: /brain/awt165 Brain 2013: 136; Comparative semantic profiles in semantic dementia and Alzheimer s disease doi:10.1093/brain/awt165 Brain 2013: 136; 2497 2509 2497 BRAIN A JOURNAL OF NEUROLOGY Comparative semantic profiles in semantic dementia and Alzheimer s disease David J. Libon, 1 Katya Rascovsky, 2 John

More information

Introduction to Physiological Psychology Review

Introduction to Physiological Psychology Review Introduction to Physiological Psychology Review ksweeney@cogsci.ucsd.edu www.cogsci.ucsd.edu/~ksweeney/psy260.html n Learning and Memory n Human Communication n Emotion 1 What is memory? n Working Memory:

More information

FDG-PET e parkinsonismi

FDG-PET e parkinsonismi Parkinsonismi FDG-PET e parkinsonismi Valentina Berti Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Sez. Medicina Nucleare Università degli Studi di Firenze History 140 PubMed: FDG AND parkinsonism

More information

Cognitive Ability (Decline) & Social Isolation

Cognitive Ability (Decline) & Social Isolation Cognitive Ability (Decline) & Social Isolation May 5, 2018 Women s Health Council of RI Doreen C. Putnam, CDP, CIPG DCPutnam Consulting www.dcputnamconsulting.com *** DISCLAIMER *** The information provided

More information

Longitudinal patterns of semantic and episodic memory in frontotemporal lobar degeneration and Alzheimer s disease

Longitudinal patterns of semantic and episodic memory in frontotemporal lobar degeneration and Alzheimer s disease Journal of the International Neuropsychological Society (2010), 16, 278 286. Copyright INS. Published by Cambridge University Press, 2009. doi:10.1017/s1355617709991317 Longitudinal patterns of semantic

More information

Department of Neurology, Kangwon National University Hospital, Chuncheon, Korea

Department of Neurology, Kangwon National University Hospital, Chuncheon, Korea Print ISSN 1738-1495 / On-line ISSN 2384-0757 Dement Neurocogn Disord 2015;14(2):87-93 / http://dx.doi.org/10.12779/dnd.2015.14.2.87 CASE REPORT DND Longitudinal Clinical Changes of Non-Fluent/Agrammatic

More information

A Healthcare Provider s Guide To Behavioral Variant Frontotemporal Dementia (bvftd):

A Healthcare Provider s Guide To Behavioral Variant Frontotemporal Dementia (bvftd): A Healthcare Provider s Guide To Behavioral Variant Frontotemporal Dementia (bvftd): Diagnosis, pharmacologic management, non-pharmacologic management, and other considerations This material is provided

More information

Screening for Cognitive Dysfunction in Corticobasal Syndrome: Utility of Addenbrooke s Cognitive Examination

Screening for Cognitive Dysfunction in Corticobasal Syndrome: Utility of Addenbrooke s Cognitive Examination Original Research Article DOI: 10.1159/000327169 Accepted: March 8, 2011 Published online: April 8, 2011 Screening for Cognitive Dysfunction in Corticobasal Syndrome: Utility of Addenbrooke s Cognitive

More information

Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia

Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia 386 Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia Shannon L. Risacher, PhD 1 Andrew J. Saykin, PsyD 1 1 Center for Neuroimaging, Department of Radiology and Imaging Sciences, and Indiana

More information

review of existing studies on ASL in dementia Marion Smits, MD PhD

review of existing studies on ASL in dementia Marion Smits, MD PhD review of existing studies on ASL in dementia Marion Smits, MD PhD Associate Professor of Neuroradiology Department of Radiology, Erasmus MC, Rotterdam (NL) Alzheimer Centre South-West Netherlands, Rotterdam

More information